ZacharyDaleGoodmanMD

Pathology • Falls Church, VA

Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Goodman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goodman's full profile

Already have an account?

Office
3300 Gallows Rd
Falls Church, VA 22042
Phone+1 301-802-1820

Fax+1 703-776-3100

Education & Training

Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1975 - 1980
Vanderbilt University School of MedicineClass of 1975

Certifications & Licensure

MD State Medical License 1979 - 2026
VA State Medical License 2010 - 2026
DC State Medical License 2010 - 2013
FL State Medical License 2010 - 2012
PA State Medical License 2010 - 2010
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

124 citations
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
James E. Everhart, Elizabeth C. Wright, Zachary D. Goodman, Jules L. Dienstag, John C. Hoefs
Hepatology. 2010-02-01
254 citations
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.
Zobair M. Younossi, Mary E. Rinella, Arun J. Sanyal, Stephen A. Harrison, Elizabeth M. Brunt
Hepatology. 2021-03-01
9 citations
An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher perc...
Zobair M. Younossi, Azza Karrar, Mariaelena Pierobon, Aybike Birerdinc, Maria Stepanova
BMC Medicine. 2018-09-12

Journal Articles

An Exploratory Study Examining How Nano-Liquid Chromatography–Mass Spectrometry and Phosphoproteomics Can Differentiate Patients with Advanced Fibrosis and Higher Perc...
Zobair M Younossi, Zachary D Goodman, BioMed Central

Press Mentions

Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver DiseaseSeptember 30th, 2020
The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
New Long-Term Data Presented at AASLD Show Reduction in Liver Fibrosis and Cirrhosis in a Cohort of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) Treated with Kanuma® (Sebelipase Alfa)November 11th, 2016